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Abstract: 
This paper reports on a comparison between nano-ZnO/CuO and nano-ZnO 
nitrocellulose membrane biosensors, both of which were fabricated using a simple and 
inexpensive sonication technique. To produce the nano-ZnO/CuO membranes, the 
technique involved sonication of 1% (w/v) ZnO and 1% (w/v) CuO nano-crystal 
colloidal suspensions, with a volume ratio of 1:2. The membranes were analysed by 
scanning electron microscopy and energy-dispersive spectroscopy, which showed the 
gradated distribution of nanoparticles in the membrane. Impedance spectroscopy 
demonstrated that the sonication resulted in a greater than two-fold enhancement of 
the output signal. Changes in impedance phase values, at a frequency of 100 Hz, were 
used to establish dose dependent responses for C-reactive protein (CRP). Limits of 
detection of 27 pg/mL for the 1% (w/v) nano-ZnO and 16 pg/mL for the 1% (w/v) 
nano-ZnO/CuO nitrocellulose membrane biosensors were demonstrated. 
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The drive to develop technology that can be used to diagnose and monitor 
disease in the community has seen the application of biosensing technology to 
measure a wide range of biomarkers. Biosensor technology enables the rapid 
measurement of biomarkers at the point of test, thereby allowing a medical decision 
on the management and/or treatment of a patient to be made immediately. Antibody-
based biosensors are well suited these applications, due to their ability to deliver high 
specificity and sensitivity, as well as being adaptable for detection of a wide range of 
analytes. For example, antibody-based biosensors have been developed for detection 
of the following: cardiac troponin-T (cTnT) [1], epidermal growth factor receptor 
(EGFR) [2], cortisol [3], brain natriuretic peptide (BNP) [4], Aflatoxin B1 (AFB1) [5] 
and insulin [6] (supporting information Table S1). A number of antibody-based 
biosensors have also been developed for measurement of C-reactive protein (CRP) 
[7–9]. CRP is a biomarker that, when elevated from a concentration of 1 mg/L to a 
level of, or above, 3 mg/L, indicates an infection or other active inflammatory 
process.  CRP is synthesised in the liver and released in response to inflammatory 
changes. It is regulated by interleukin-6, interleukin-1β and tumour necrosis factor-α 
[10] and is thought to be a key biomarker of systemic inflammation [11].  
Numerous biosensor fabrication processes are described in the literature, but in 
recent years, there has been much focus on the application of nano-materials, 
including the use of metal oxide nano-crystals, such as zinc oxide (ZnO). ZnO is a 
functional n-type semiconductor, with a wide band gap of 3.37 eV at room 
temperature [12]. Distinctive features of ZnO include good electrical transport, good 
biocompatibility, cost effectiveness, chemical stability and a high isoelectric point, 
allowing better absorption of biomolecules by electrostatic interactions [13,14]. In 
addition, the benefits of utilising nanostructures to form a biosensor surface include 
the high surface area, the effect of nano-confinement to enhance biosensor sensitivity 
and the ability to tailor the particles/surface in a controlled manner to adapt 
nanostructure biosensors for detection of a range of analytes [1,13,15]. Shen et al. 
developed a series of thin film transistor (TFT) biosensors for detecting biomarkers of 
tumours [2]. They applied anti-EGFR antibodies to a ZnO nano-surface to detect 
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EGFR [2]. The electrical charge on the sensing pad was modified by proteins, 
inducing corresponding charges in the TFT forming a conducting channel and 
increasing the current output with changes in the concentration of EGFR [2]. This 
study showed that, compared with the TFT biosensor without ZnO nanorods, a device 
with nanorods had a 4.7 times enhanced output because the ZnO nanorods helped to 
attract proteins due to the possession of more static charges and a larger surface-to-
volume ratio [2]. Copper Oxide (CuO) is a p-type semiconductor with a narrow band 
gap of 1 eV to 1.57 eV [16]. The improvement in sensing performance of ZnO/CuO 
composites has been attributed to many factors, including increased interfacial 
potential barrier energy associated with the formation of p-n junctions resulting in a 
higher resistance and an enhanced surface area to support greater antibody loading 
[17]. 
Various methods for fabricating ZnO and CuO nanostructures, with and 
without substrates, have been reported. A relatively simple and inexpensive way is to 
fabricate ZnO and ZnO/CuO films involves sonication. Choosing suitable solvent 
media and dispersing agents during sonication helps interrupt the binding forces 
between individual particles by combining both chemical and physical approaches 
[18]. The sonication power results in improved dispersal of the colloidal suspension. 
Zhang et al. described a method for preparing titanium dioxide (TiO2)-modified 
carbon paste electrodes [19]. Firstly, the titanium dioxide hollow microsphere colloid 
powder was added to Britton–Robinson buffer solution and sonicated to produce a 
well-dispersed colloid solution. Then the well-dispersed solution was dropped on to a 
surface and dried in air. Lastly, the electrodes were washed with ultrapure water [19]. 
Al-Hinai et al. demonstrated that ZnO nanoparticles in deionized water could be 
dispersed by probe sonication, followed by magnetic stirring for 24 h, and then 
mixing with Polyethersulfone (PES) dissolved in 1-Methyl-2-pyrrolidone (NMP) and 
stirring for a further 24 h [20]. The nanoparticles were then cast on a flat glass plate in 
a water bath overnight to hydrothermally produce ZnO nanorods [20]. Lee et al. 
fabricated a platform for biocompatible antibacterial applications using ultrasound-
assisted sonochemistry to fabricate a flexible ZnO nanopillar array film within 5 min 
[21]. The method utilised extremely high temperature (>5000 K), pressure (>200 
MPa), and cooling rate (>107 K-1) in a liquid medium under sonication [21]. 
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A number of researchers have recognised the benefits of ZnO/CuO composites 
in biosensor fabrication. Widiarti et al. found that the addition of CuO decreased the 
band gap energy of the composite and observed that this enhanced the antibacterial 
activity [22]. They speculated that this was due to electrons being easily excited from 
the valence band to the conduction band, causing the formation of reactive oxygen 
species and superoxides [22]. In addition, it was suggested that CuO-ZnO composites 
demonstrated enhanced antibacterial activity due to the presence of Zn2+ ions and the 
generation of reactive oxygen species causing bacterial membrane lipid peroxidation. 
[22,23]. Reported advantages of biosensors fabricated using ZnO/CuO composites 
compared with ZnO nanostructures include improved linear range, lower limits of 
detection, shorter response times and greater sensitivities [24,25]. Sonication has also 
been shown to have benefit in relation to fabrication of ZnO/CuO biosensors. Our 
research group has investigated the fabrication of biosensors formed from ZnO/CuO 
nano-crystals coated on polyethylene terephthalate (PET) substrates [26,27]. In this 
work, we achieved improved reproducibility in fabricating ZnO/CuO nano-surfaces 
by sonicating 1% (w/v) ZnO and 1% (w/v) CuO nano-crystal suspensions [26,27]. 
Optimum signal output was achieved with mixed suspensions in volume ratios 1:2 
(ZnO:CuO) [26]. 
Three-dimensional membranes are widely used in biosensing. Recently their 
utilisation alongside ZnO nanoparticles has been reported. For example, Al-Hinai et 
al. grew ZnO nanorods on the top surface of a PES membrane on a flat glass plate to 
form a biosensor [20]. Munje et al. developed a flexible biosensor, including a ZnO 
thin film active region by deposition of nanoparticles on to a nanoporous polyamide 
membrane. This methodology enhanced the diffusion time associated with the mass 
transport within the nanopores and provided a high surface to volume ratio to enhance 
the detection capability [28]. Munje et al. utilised a nano-porous ZnO thin film as an 
active sensor substrate, noting that the electrical double layer formed at the liquid-
semiconductor interface was amplified in the presence of the nano-porous substrate 
with an associated enhancement in charge accumulation [3]. However, there have 
been no previous reports of impregnating a porous membrane with ZnO (or CuO) to 
form the active layer of a biosensor, as described in this paper. 
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Here we report on the fabrication and evaluation of nano-ZnO and nano-
ZnO/CuO nitrocellulose membrane biosensors, formed using a colloidal sonication 
technique. The biosensors are label-free and non-faradaic, i.e. there is no charge 
transfer between the biomolecule complex and the sensor electrodes [4]. In this study, 
we analysed the membranes using scanning electron microscopy (SEM) and energy-
dispersive spectroscopy (EDS) analysis and we characterised performance of the 
biosensors by the measurement of CRP using impedance spectroscopy. For non-
faradaic impedimetric biosensors, at the liquid-semiconductor interfaces, the electrical 
double layer forms a large interfacial capacitance with high density of charge 
accumulation [3]. This capacitance changes actively with the concentration of 
biomolecular binding [3] and in this work, excellent limits of detection for the 





2. Materials and Methods 
2.1 Membrane Preparation 
Fabrication process for the 1% nano-ZnO nitrocellulose membranes: - In our 
work, 0.6 g ZnO nanoparticles (ZnO, 99.9+%, 80 - 200 nm from US Research 
Nanomaterials Inc.) were added to 60 mL double-distilled water. 1% ZnO suspension 
was stirred for one hour at room temperature. A 1% (w/v) ZnO suspension was stirred 
for 1 h at room temperature. Nitrocellulose blotting membranes (Sartorius) with 0.45 
μm pore size were cut using a Biodot guillotine to form a 15 mm × 15 mm square.  A 
number of the membranes were immersed in the ZnO colloidal suspension and 
sonicated for 15 min in a sonication bath (Langford Ultrasonics) with a power of 
300W at 40 Hz. Other membranes were immersed for 15 min without sonication for 
comparison. Finally, all the membranes were rinsed in deionised water 3 times and 
dried in sealed box with silica gel before being used for the immobilisation of 
antibody. 
Fabrication process for the 1% nano-ZnO/CuO nitrocellulose membranes: - In 
the process 0.2 g ZnO nanoparticles and 0.4 g CuO nanoparticles (CuO, 99.5+%, 
width 10 - 30 nm, Length: 200 – 800 nm from US Research Nanomaterials Inc.) were 
added to 60 ml double deionized water. 1% ZnO (w/v) was mixed with 1% CuO (w/v) 
nanopowders in water for 1 h to give 1:2 (v/v)/(wt%:wt%) ZnO/CuO colloidal 
suspension. Nitrocellulose membranes were then soaked in the ZnO/CuO suspension 
and subjected to sonication for 15 min as described above; other membranes 
immersed for 15 min were without sonication for comparison. Finally, the membranes 
were rinsed using deionised water 3 times and dried in atmosphere with silica gel 
before being coated with antibody. 
 
2.2 Characterization of Membranes 
The cross section of a nanoparticle nitrocellulose membrane was prepared 
using a double edge razor blade and examined using a FEI Quanta 650 field emission 
scanning electron microscope (ESEM) with Everhart-Thornley Detector (ETD). The 
morphology of cross sections of untreated nitrocellulose membranes, a nano-ZnO 
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nitrocellulose membrane and a nano-ZnO/CuO nitrocellulose membrane, were 
analysed. To perform the SEM analysis, samples were mounted on an aluminium stud 
and coated with a thin layer of Au using an Emscope SC500 Gold sputter coating unit 
prior to analysis. For the ZnO/CuO nitrocellulose membrane, a Gaseous Secondary 
Electron Detector (GSED), with a high pressure at 3 Torr, was also used in the SEM.  
EDS (Oxford Instruments AZtec EDS) was used to analyse the chemical 
compositions of the sonicated nano-ZnO and nano-ZnO/CuO nitrocellulose 
membranes.  
 
2.3 CRP Sensor Fabrication and CRP Assay 
To prepare the membranes for the assays, 40 μl (200 ng) of monoclonal mouse 
anti-human C-reactive protein (4C28, from HyTest Ltd, Turku, Finland) was diluted 
in 5 mM phosphate buffered saline (PBS) at pH 7.4 (OXOID Microbiology products). 
The capture antibody was immobilised on to the nitrocellulose membranes (from the 
upper side to lower side) until it was fully wet. The anti-CRP antibody was readily 
immobilised in the membrane through electrostatic interaction as the ZnO 
nanostructures distributed within the nitrocellulose membrane were positively charge 
(as the pH of the buffer was 7.4 and the isoelectric point of ZnO and CuO is around 
9.5 [29,30]), whereas the anti-CRP antibody used in this study is predominantly 
negatively charged. The membranes were then dried in a desiccator with silica gel at 4 
°C overnight for 18 h. Anti-CRP antibody is immobilised on membrane not only 
through electrostatic interaction, but also other physical absorption processes, such as 
hydrophobic interactions and van der Waal’s forces, forming non-covalent 
interactions. Wang et al. schematically presented the capacity of antibody 
immobilization on 3D matrix compared with a conventional 2D surface, to illustrate 
that it is much higher, shown in Schematic 1 [31]. This work confirmed that the 





Schematic 1. Random immobilization of capture antibody (a) on a 2D surface and (b) 
on a 3D membrane. (Adapted from [31]) 
 
After the overnight incubation, the nano-particle nitrocellulose membranes 
were repeatedly (4 times) immersed in 5 mM PBS and then blocked with 1% (w/v) 
skimmed milk for 30 s. 
Human C-reactive protein (CRP) (8C72, from HyTest Ltd, Turku, Finland) 
was diluted in 5 mM PBS. Then, 40 μl of CRP at different concentrations were placed 
on the membranes to facilitate a slow liquid absorption in to the membrane until it 
was fully wet. The specific concentrations of CRP were as follows: 0 (PBS only), 0.1, 
0.5, 1, 5, 10, 15 ng/mL. 
During the impedance testing, the membranes were laid on a glass coverslip 
(from Deltalab, 22 mm × 22 mm and 0.13 - 0.16 mm thick), and positioned on a 23 
mm diameter D-shape electrode pair with 1 mm gap, with the lower layer and hence 
the highest density of nanoparticles closest to the electrode. (The gradated porosity 
and associated variation in nanoparticle density are described in section 3). A second 
coverslip was placed on top of the membrane to prevent evaporation during the 
measurement. The schematic diagram of the arrangement is shown in Schematic 2. 
The impedance amplitude and phase angle were measured and analysed after 10 
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minutes incubation time with the added CRP. The impedance values were recorded at 
each concentration of antigen, with 3 replicates of the nano-particles/nitrocellulose 
membranes, measured from 10 Hz to 4 MHz. 
 
Schematic 2. Illustration of the ZnO nanoparticle nitrocellulose membrane 
sandwiched between two coverslips positioned above the electrodes.  
 
A Cypher Instruments C60 Impedance-Amplitude-Phase Analyser was used to 
measure the impedance change of the nano-particles nitrocellulose membranes 
associated with antibody/antigen interactions. The frequency was scanned from 10 Hz 
to 4 MHz, with 300 test points, at an AC peak-to-peak voltage of 2 V with a DC offset 
of 0.9 mV. The impedance plots were analysed by Cypher Graph V1.21.0, Impedance 
Amplitude and Phase Analyser graphing application software. The change of 
impedance amplitude and phase angle was evaluated as function of antigen (CRP) 
concentration in the buffer. Rather than correlate the overall impedance to different 
concentrations of CRP, we determined a single frequency to give the maximum 
relative changes and a stable reading [4]. The sensor responses were taken at a 
frequency of 100 Hz. Phase changes with ZnO and ZnO/CuO (1:2) nanoparticle 
nitrocellulose membrane were compared with or without sonication. The phase 
change was defined as the difference of the impedance phase value of the biosensor 
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after 10-min incubation with CRP and the phase angle of the control. Results were 
plotted using a logarithmic scale on the x-axis.  
 
2.4 Statistical Analysis 
A 4-parameter linear-log logistic curve, with the error bars, was created using 
R. The estimated limit of detection (LoD) was defined as the mean of the intercept on 
the y axis of the calibration curve, plus 3 times the standard deviation of the intercept 
and calculated using R. The mean value and Standard deviation of the “intercept” at 
the working zero found using the 4-parameter logistic curve. 
The coefficient of variation %CV = (Standard Deviation/Mean*100) was used 
to demonstrate reproducibility for each membrane type. 
A Wilcoxon rank sum test was used to analyse the differences in phase 
changes between ZnO and ZnO/CuO (1:2) nano-membranes with and without 
sonication at each concentration, the level of significance was defined as p<=0.05. 
Analysis was performed using R. 
 
3. Results and Discussion 
3.1 Characterization of Membrane 
The nitrocellulose membranes used in this study showed gradated porosity 
(Figure 1) and, as seen in the scanning electron micrograph of Figure 1(a), can be 
divided into three layers. The upper layer has the smallest pore sizes and structures 
shown in Figure 1(b), whereas the lower layer has a loose pore structure between the 
white support matrix as shown in Figure 1(d). The horizontal lines visible in the 
white fillers indicate the cutting direction of the nitrocellulose membrane. The 
nitrocellulose membrane is manufactured by casting the nitrocellulose in solvents, 
which causes the significant asymmetry in the porous structures due to the 




Fig. 1. Scanning electron micrographs of the nitrocellulose membrane cross-section: 
(a) whole cross section at 1,000× magnification; (b) upper layer of nano-
ZnO/nitrocellulose membrane (with small pore structures) at 30,000× magnification; 
(c) middle layer of nano-ZnO/nitrocellulose membrane (with bigger and loose pore 
structures) at 30,000× magnification; (d) lower layer of nano-ZnO/nitrocellulose 
membrane (with biggest pore structures) at 30,000× magnification. 
 
During the fabrication of the nano-particle nitrocellulose membranes, the 
membranes were incubated in nano-particle colloidal suspensions. Figures 2(a) to 
2(c) show scanning electron micrographs of the three layers of the nitrocellulose 
membrane. A smaller number of nanoparticles entered the upper structure due to the 
lower porosity, as seen in Figure 1(a). The nanoparticles easily entered the lower 
layer of the membrane as seen in Figure 1(c) by the force of sonication and then 
diffused into the middle layer, as shown in Figure 1(b). Figure 2(c) clearly shows a 
high number of the columnar wurtzite structures of the ZnO nanoparticles in the lower 
layer of the nitrocellulose membrane.   
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Imaging of the conductive nano-ZnO/CuO nitrocellulose membrane was 
performed using a Gaseous Secondary Electron Detector, as the CuO particles became 
charged under normal SEM conditions (seen as lighter areas at nano-crystal margins), 
and are shown in Figures 2(d) to 2(f). As with the ZnO membranes, Figures 2(d) to 
2(f) show an increasing number of ZnO and CuO nanoparticles distributed within the 
membrane, with the highest density of the CuO nanoparticle flakes and columnar 
wurtzite structure of ZnO in the lower layer of the nano-ZnO/CuO membrane. Figure 
2 also reveals that the ZnO/CuO nanostructures formed a larger number of voids 
compared with ZnO, which is beneficial for the antibody capture. 
 
 
Fig. 2. Scanning electron Micrographs of nano-ZnO nitrocellulose membrane cross-
section at 80,000× magnification: (a) upper layer; (b) middle layer; (c) lower layer. 
Scanning electron Micrographs of nano-ZnO/CuO nitrocellulose membrane cross-




3.2 EDS Results 
From the scanning electron micrographs, both ZnO and CuO nanoparticles 
were observed to be densest in the lower layer of the membrane, so the EDS analysis 
was performed on the lower layer. The result of atomic composition analysis by EDS 
on the cross-section of the nano-ZnO and nano-ZnO/CuO nitrocellulose membrane is 
shown in Figure 3 and Figure 4. The following elements were detected: C, (Cu,) O, 
Zn and Au. Figure 3 shows the results for zinc; 5(a) is the SEM image, 5(b) is the 
EDS spectrum and in Figure 3(c) the yellow areas show the regions where the Zinc is 
concentrated. Figure 4 shows the results of the EDS analysis on the ZnO/CuO 
membrane. The distribution of the 6 elements within the lower layer of the 
nitrocellulose membrane is shown in Figure 4(b). The intensity of the coloured areas 
highlights the element location and loading within the matrix. The nanoparticle 
density was greatest between the fibres of the support matrix of the membrane, which 
also had the largest pore size within the layer. A small amount of Al was detected at 
the edge of the membrane, from the SEM stub. Referring to Figure 4(a), the carbon 
originates from the nitrocellulose and Au from the sputtered layer used in the sample 
preparation. The grayscale intensity of the zinc and copper in Figure 4(a), had a ratio 
of Zn to Cu 1:2.08, corresponding to 1:2 ratio of ZnO/CuO in the original 
nanoparticle colloid suspension. This confirmed that the fabrication methodology 





Fig. 3. SEM/EDS spectrum/mapping showing the distribution of Zn on the lower 
layer cross-section of the nano-ZnO membrane: (a) SEM image; (b) EDS spectrum 





Fig. 4. EDS spectrum/mapping on the lower layer cross-section of the nano-ZnO/CuO 
membrane: (a) EDS spectrum and (b) EDS mapping of the elements: O, C, Au, Cu, 
Zn and Al. 
 
3.3 Calibration Curves Using Different Nano-membranes with Capture 
Antibody 
Figures 2(d) to 2(f) and Figure 4(b) evidence that the ZnO/CuO nanoparticles 
are distributed within the porous membrane following sonication. The cross section of 
the biosensor developed in this study is schematically depicted in Schematic 2. This 
shows the sensing nanoparticle nitrocellulose membrane with antibody coating, which 
is sandwiched between two glass cover slips and positioned above two electrodes. The 
electrodes face the lower layer of the membrane, which was loaded with nanoparticles 
for capturing biological molecules. Impedance spectroscopy was used to quantify 
binding of CRP to the antibody on the nano-ZnO/CuO membranes, with and without 
sonication, and the nano-ZnO membranes, with and without sonication, for these non-
faradaic biosensors.  
The impedance was recorded for CRP concentrations between 0 ng/ml and 15 
ng/ml, with 3 replicate nano-ZnO and ZnO/CuO membranes with or without 
sonication and with or without antibody immobilised, over the frequency range 10 Hz 
to 4 MHz (bode plots are shown in the supporting information Figure S1-2). In this 
study the most significant changes were observed below 1 kHz, around 100 Hz. This 
observation concurred with other published work. Selvam et al. measured the 
impedance of their non-faradaic biosensor over the frequency range 100 Hz to 1 MHz 
and found the changes to the double layer capacitance were most significant at 
frequencies less than 1 kHz [4]. Kinnamon et al. selected 100 Hz for their calibration 
dose response, as this maximised the percentage change in impedance relative to the 
baseline measurement, performed post-antibody functionalization [33]. 
 Figure 5 shows the impedance amplitude and phase values measured on both 
the nano-ZnO membranes and the nano-ZnO/CuO membranes with different 
concentrations of CRP after a 10-min incubation at 100 Hz, the mean of 3 replicates. 
For both the nano-ZnO membranes and the nano-ZnO/CuO membranes, the 
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impedance decreases with CRP concentration. As both ZnO and CuO are 
semiconducting materials, an electrical double layer is formed when they interact with 
the liquid electrolytes, resulting in charge accumulation at the interface region. When 
binding of the CRP molecules (~116 kDa) to the antibodies occurs adjacent to this 
interface, the double layer capacitance is enhanced, resulting in the observed change 
in the impedance. Note that in Figure 5C, the error bars of impedance response on 
nano-ZnO/CuO membranes look large compared with the other plots. This is due to 
the fact that the range of the impedance change is small, thus the scale is magnifying 
the error bars. From Figure 5, the lines of best fit have lower residuals for the phase 
angle compared with the amplitude of the impedance. Consequently, subsequent 
calibration curves were plotted using the change in the absolute phase relative to the 
PBS control using a logarithmic scale on the x-axis.  
 
 
Fig. 5. Impedance amplitude/kOhms (Z/kΩ) and phase change/degree (φ/°) on nano-
ZnO nitrocellulose membranes (n=3) and nano-ZnO/CuO nitrocellulose membranes 
(n=3) after a 10-minute incubation time with increasing concentrations of CRP, 




Figure 6 shows the phase change for six different nano-particle/nitrocellulose 
membranes at a frequency of 100 Hz. In Figure 6, the average phase change of 
samples fabricated without the sonication stage (the red bar represents nano-ZnO 
membrane and the light blue bar represents nano-ZnO/CuO membrane) is lower 
compared with the phase change for samples prepared with sonication (the green bar 
represents nano-ZnO membrane and the pink purple bar represents nano-ZnO/CuO 
membrane). The phase change for nano-ZnO/CuO membrane after sonication 
approximately doubles compared with no sonication, whereas for the nano-ZnO 
membrane there is an approximate 3-fold increase. This indicates that the sonication 
has a greater effect on ZnO nano-particles than on the ZnO/CuO mixture in terms of 
signal enhancement. These results demonstrate the importance of the sonication 
process in the fabrication of the biosensor. However, despite this, the ZnO/CuO 
membranes remain superior in terms of the amplitude of the signals relative to the 
control. The sonication had a highly significant effect on the signal generated from the 
membranes (p<0.0005 by Kruskal-Wallis chi-squared test).  
 
 
Fig. 6. Impedance phase change/degree (∆φ/°) response to seven concentrations of 
antigen (CRP) on the six different types of membrane. For the 3 nano-ZnO 
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membranes (n=3): with 200 ng capture antibody and without sonication (red), without 
capture antibody and with sonication (yellow) and with 200 ng capture antibody and 
with sonication (green). For the 3 nano-ZnO/CuO membrane (n=3): with 200 ng 
capture antibody and without sonication (light blue) and without capture antibody but 
with sonication (dark blue), with 200 ng capture antibody and with sonication (pink 
purple).   
 
Table 1 shows pairwise comparisons, using a Wilcoxon rank sum test, on four 
types of membranes with antibody immobilised. The phase responses of the 
nitrocellulose membranes show a significant difference between sonicated and non-
sonicated membranes for both the nano-ZnO and ZnO/CuO membranes (p<0.05).  
 
Table 1. The significant differences in the membrane treatment analyzed by a 
Wilcoxon rank sum test among four different nano-particles/nitrocellulose 
membranes with antibody immobilised. 
A Wilcoxon rank sum test ZnO-ns ZnO/CuO-ns ZnO/CuO-s 
ZnO/CuO-ns 0.019 - - 
ZnO/CuO-s 0.013 0.013 - 
ZnO-s 0.013 0.054 0.024 
 
Figure 6 also shows the phase change for both nano-ZnO membrane and 
nano-ZnO/CuO membrane biosensors without capture antibody, but blocked with 
skimmed milk. The results were significantly lower than those obtained with the 
membranes containing antibody. Unsurprisingly the composition of the membranes 
was not statistically significant with respect to the biosensors with no capture 
antibody (p=0.565). This control did show a slight increase in signal output with 
increasing concentrations of CRP, which can be attributed to non-specific binding of 
CRP to proteins on the surface.  
With antibody in the membranes, for both the nano-ZnO membrane and the 
nano-ZnO/CuO membrane, dose response relationships were evident from Figure 6. 
This indicates that the charge interactions of antigen binding with antibody resulted in 
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significantly larger output signals. It is speculated that there is increased charge 
accumulation due to the bound antigen on the surface compared with the non-specific 
binding of CRP. 
The coefficient of variation (CV) was used to compare the variability of the 
data from ZnO with that from the ZnO/CuO membranes, with 200 ng anti-CRP. The 
average CV of the phase response at each concentration of CRP for the nano-
ZnO/CuO (1:2) membrane is 9.6% compared with 15.6% for the nano-ZnO 
membrane, i.e. the ZnO/CuO membrane has better reproducibility. The ZnO/CuO 
membrane and ZnO membrane without sonication show CVs of 12.6% and 28.5% 
respectively. This demonstrates that the sonication stage of the fabrication process 
improved the reproducibility of nanoparticle membranes and the sonication process 




Fig. 7. Phase change/degree (∆φ/°) response versus antigen (CRP) concentration for 
sonicated nano-ZnO nitrocellulose membranes (red) and nano-ZnO/CuO 
nitrocellulose membranes (blue) with capture antibody (n=3) measured at the 




The 4-parameter logistic curve fits of the phase change data for both nano-
ZnO and nano-ZnO/CuO membranes with sonication are shown in Figure 7. From 
these dose response curves, the regression line associated with the data from the nano-
ZnO membranes has a R2 value of 0.9645 and from the data of the nano-ZnO/CuO 
membranes, the R2 value is 0.9744. It can be seen that the dose response curve with 
nano-ZnO membrane appears to become saturated at CRP concentrations above 
approximately 5 ng/mL, while with nano-ZnO/CuO membrane appears to saturate at 
approximately 15 ng/mL. The addition of CuO enabled an average enhancement of 
1.4 times a greater signal across the range of 0.1 to 15 ng/mL. One explanation of this 
difference is the enhanced effect of nano-confinement in the ZnO/CuO membrane 
biosensor. This occurs when binding molecules are matched in size to the voids in the 
nanoparticle structure, resulting in charge screening due to the electric field 
distribution inside the structure [28]. Figure 2 shows that the ZnO/CuO membranes 
have a closer packed structure with smaller voids, due to the smaller size of the CuO 
nanoparticles.  
Table 2 shows the comparison of LoDs of nano-ZnO and nano-ZnO/CuO 
membranes with and without sonication. The LoD for the 1% nano-ZnO sonicated 
membranes with 200 ng anti-CRP was calculated to be 27 pg/ml, while the LoD for 
1% nano-ZnO/CuO (1:2) sonicated membranes with 200 ng anti-CRP was 16 pg/ml. 
Table 2 shows that the sonication has made a significant difference to the LoD on 
nano-ZnO/nitrocellulose membrane. The nano-ZnO/nitrocellulose membrane is a 92.6 
times improvement, while nano-ZnO/CuO nitrocellulose membrane is a 1.25 times 
improvement. Both nano-ZnO/CuO nitrocellulose membranes with and without 
sonication show enhanced behaviours, i.e. lower limits of detection. It is hypothesised 
that the better detection limit and reduced enhancement due to sonication observed 
with the ZnO/CuO membranes is due to a decrease in the size to the voids in the 
nanoparticle structure compared with the ZnO membranes. This enhances the effect of 
nano-confinement, as described above, resulting in amplification of the signal and a 
smaller number of binding events being required to bring the signal above the noise 




Table 2. Limits of detection of the phase change calibration curve for non-
















2.5 ng/mL 27 pg/mL 20 pg/mL 16 pg/mL 
 
In many articles in the literature, CRP is utilised as the model analyte to 
characterise new types of biosensor. A number of examples of sensitive CRP 
biosensors are listed in the supporting information, Table S2, and a selection is 
highlighted below. Dong et al. developed a paper-based microfluidic lateral flow 
immunoassay using gold nanoparticles to deliver a colorimetric output [7]. The key 
advancement presented related to the integration of the sensor with a smartphone 
using a microlens [7]. The assay was able to detect the target protein up to 2 µg/mL, 
however the detection limit was only 54 ng/mL and thus substantially inferior to the 
value presented in this work [7]. Justino et al. adopted the approach of enhancing 
sensitivity with nanoparticles, using carbon nanotubes on the sensor surface of a field-
effect transistor. This showed improved performance for CRP detection, with a LoD 
of 0.1 ng/mL [34].  
Impedimetric biosensors for detection of CRP have been developed by a 
number of research groups. For example, Bryan et al. presented a sensitive and 
reusable biosensor, using a well-established technique of analysing the charge transfer 
resistance to determine the CRP level [35]. A LoD of approximately 19 ng/mL was 
presented [35]. Yagati et al. also developed a faradaic impedimetric biosensor. This 
research team realised the benefit of using nanoparticles, utilising graphene oxide to 
achieve an improved LoD of 0.08 ng/mL [9]. However, compared with all these 
previous studies, the non-faradaic impedimetric nano-ZnO and nano-ZnO/CuO 
membrane biosensors presented in our paper, show excellent limits of detection. 
The advantages of the non-faradaic impedimetric methodology are reinforced 
by reports in the literature. Lin et al. developed a non-faradaic biosensor for CRP 
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using a nano-porous alumina membrane as the sensor surface, rather than ZnO/CuO 
nanoparticles within a 3D membrane, as described in this paper. However, the 
approach also resulted in a low value for the LoD, i.e. 1 pg/mL. The advantages 
associated with the simplicity of measuring a change in capacitance were also 
highlighted [36]. Tanak et al. developed a non-faradaic electrochemical impedance 
spectroscopy-based biosensor for detection of CRP. In this case, 100 nm thin film of 
ZnO, deposited on the gold interdigitated electrodes was used and a LoD of 0.01 
μg/mL in serum was achieved [37]. Neither of these studies utilised, ZnO or CuO 
nanoparticles nor a nanoporous membrane and they did not include an insulating layer 
between the electrodes and the sensor surface. However, the low LoD values, 
evidence the promising nature of the non-faradaic approach. 
 
4. Conclusion 
Both nano-ZnO nitrocellulose membrane and nano-ZnO/CuO nitrocellulose 
membrane biosensors can be fabricated using a simple and inexpensive colloidal 
sonication technique. Following fabrication, the cross section of nitrocellulose 
membrane contained increased densities of nanoparticles from the upper to the lower 
layers. The loading of ZnO and CuO nanoparticles within the membrane remained in 
proportion to the concentration of each type of nanoparticle within the original 
colloidal suspension. The sonication force is critical to assist the nanoparticles to be 
embedded into the lower layer of the membrane.  
The addition of CuO nanoparticles of nano-ZnO/CuO nitrocellulose 
membrane biosensors showed enhancement of performance on impedance 
spectroscopy at 100 Hz across a concentration range of 0.1 ng/ml to 15 ng/mL CRP.  
The nano-ZnO nitrocellulose membrane biosensors revealed dose dependent 
responses with saturation occurring at approximately 5 ng/ml. The sonicated nano-
ZnO and nano-ZnO/CuO nitrocellulose membranes showed limits of detection of 27 
and 16 pg/mL respectively. Sonication during biosensor fabrication enhanced 
performance, with the nano-ZnO membrane showing an approximate 3-fold increase 
and the nano-ZnO/CuO nitrocellulose membrane showing an approximate 2-fold 
increase in phase change with sonication. The nano-ZnO/CuO nitrocellulose 
membrane with sonication showed the optimum results in terms of the highest 
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gradient and broadest detection range. Further work is being carried out to fully 
evaluate the biosensor and improve reproducibility, particularly through automating 
the fabrication process. 
In addition to the simple and inexpensive fabrication methodology, which is 
compatible with large scale manufacture, and the excellent limits of detection, other 
advantages of this biosensor fabrication technique include the lack of contact between 
electrodes and measurement matrix and the fact that no redox active species are 
required. This biosensor fabrication methodology can be adapted to the measurement 
of any other analytes where an appropriate biological binding partner can be obtained 
and may be particularly suited to measurements, where high sensitivity or low sample 
volumes are required. These benefits make it a promising technique for adaption as a 
wearable biosensor. 
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